Facilitated By

San Antonio Medical Foundation

Developing Fluorescent CDK 4/6 Inhibitors to Guide Triple Negative Breast Cancer Surgery

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Usama, Syed Muhammad
Funded by
Voelcker Fdn
Research Start Date
Status
Active

Basic Research

Collaborative Project
Basic Research
Cancer